lin he - Genetic Mutations

Author Information

Lin He is affiliated with the Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science at Shanghai Jiao Tong University in Shanghai, China.

Research Contributions

Lin He has made significant contributions to the field of genetics, particularly focusing on psychiatric and neurodevelopmental disorders. His recent works include studies on genetic risk factors for clozapine-induced leukopenia and neutropenia, the association of specific SNPs with bipolar disorder, genetic responses to antidepressants, and markers for predicting violence in schizophrenia. His studies often involve Chinese Han populations, emphasizing pharmacogenetics and the interaction of genetic and environmental factors in mental health.

Aliases

No aliases were provided for Lin He in the given data.

Publication and Citation Metrics

Metric	Value
Citation Count	11,920
h-index	55
Paper Count	313

Publications:

Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study

DOI: 10.1038/s41398-021-01470-z

Year: 2021

A Functional SNP rs895819 on Pre-miR-27a is Associated with Bipolar Disorder by Targeting ICAM-1.

DOI: 10.21203/RS.3.RS-231475/V1

Year: 2021

Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression

DOI: 10.1016/j.pnpbp.2020.110036

Year: 2021

Candidate symptomatic markers for predicting violence in schizophrenia: A cross-sectional study of 7711 patients in a Chinese population.

DOI: 10.1016/j.ajp.2021.102645

Year: 2021

No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.

DOI: 10.1097/WNF.0000000000000436

Year: 2021

Association between SLC17A7 gene polymorphisms and venlafaxine for major depressive disorder in a Chinese Han population: a prospective pharmacogenetic case-control study

DOI: 10.1097/JBR.0000000000000096

Year: 2021

Interaction of CEND1 gene and life events in susceptibility to depressive symptoms in Chinese Han college students.

DOI: 10.1016/j.jad.2020.09.082

Year: 2020

Identification of de novo mutations in prenatal neurodevelopment-associated genes in schizophrenia in two Han Chinese patient-sibling family-based cohorts

DOI: 10.1038/s41398-020-00987-z

Year: 2020

Sex-specific association of MC2R polymorphisms and the risk of major depressive disorder in Chinese Southern Han.

DOI: 10.1097/YPG.0000000000000271

Year: 2020

A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients

DOI: 10.1016/j.psychres.2019.112690

Year: 2020

How do Acridine Dyes Cause Mutations?

What is the Future of Third Generation Sequencing?

How Does Hydroxyurea Help in Sickle Cell Disease?

Are There Potential Treatments Targeting Genetic Mutations?

Can Inherited Mutations Be Treated or Managed?

What is Precision Medicine?

Are There Any Preventive Measures for Asbestos-Induced Genetic Mutations?

Can Genetic Susceptibility Influence Mutation Risk?

Should Genetic Mutations Be Patented?

What is the Role of Epigenetics in Brain Development?

Partnered Content Networks

Relevant Topics